Evidence map›Paper›PMID 38709327›Full record

ArticleWorld journal of urology2024

Illumination matters Part II: advanced comparative analysis of flexible ureteroscopes in a kidney model by PEARLS.

Jia-Lun Kwok, Frédéric Panthier, Vincent De Coninck, Eugenio Ventimiglia, Yazeed Barghouthy, Alexandre Danilovic, Niamh Smyth, Jan Brachlow, Florian Alexander Schmid, Cédric Poyet and 3 more

Abstract readComparative Study
In one paragraph

Article in World journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jia-Lun KwokDepartment of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-9758-6225
Frédéric PanthierProgressive Endourological Association for Research and Leading Solutions (PEARLS), Paris, France.ORCID http://orcid.org/0000-0003-3055-2984
Vincent De ConinckProgressive Endourological Association for Research and Leading Solutions (PEARLS), Paris, France.ORCID http://orcid.org/0000-0002-4983-5055
Eugenio VentimigliaProgressive Endourological Association for Research and Leading Solutions (PEARLS), Paris, France.ORCID http://orcid.org/0000-0003-3654-1629
Yazeed BarghouthyProgressive Endourological Association for Research and Leading Solutions (PEARLS), Paris, France.ORCID http://orcid.org/0000-0001-6755-0611
Alexandre DanilovicProgressive Endourological Association for Research and Leading Solutions (PEARLS), Paris, France.ORCID http://orcid.org/0000-0002-6963-6117
Niamh SmythProgressive Endourological Association for Research and Leading Solutions (PEARLS), Paris, France.
Jan BrachlowProgressive Endourological Association for Research and Leading Solutions (PEARLS), Paris, France.ORCID http://orcid.org/0000-0003-1246-9407
Florian Alexander SchmidDepartment of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-0862-5027
Cédric PoyetDepartment of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-3648-6941
Daniel EberliDepartment of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-8866-8010
Olivier TraxerProgressive Endourological Association for Research and Leading Solutions (PEARLS), Paris, France.ORCID http://orcid.org/0000-0002-2459-3803
Etienne Xavier KellerDepartment of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland. etiennexavier.keller@usz.ch.ORCID http://orcid.org/0000-0003-1667-7609

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of the study was to evaluate illumination properties in an in-vitro kidney calyx model in saline. DESIGN AND

methodsWe evaluated a series of contemporary flexible ureteroscopes including the Storz Flex-Xc and Flex-X2s, Olympus V3 and P7, Pusen 7.5F and 9.2F, as well as OTU WiScope using a 3D-printed closed pink kidney calyx model, submerged in saline. A spectrometer was used for illuminance and color temperature measurements at different openings located at center (direct light), 45° (direct and indirect light) and 90°(indirect light) to the axis of the scope.

resultsMaximum illuminance was at the center opening for all scopes (range: 284 to 12,058 lx at 50% brightness and 454 to 11,871 lx at 100% brightness settings). The scope with the highest center illuminance (Flex-Xc) was 26 times superior to the scope with the lowest illuminance (Pusen 7.5Fr) at 100% brightness setting. For each scope, there was a peripheral illuminance drop ranging from - 43 to - 92% at 50% brightness and - 43% to - 88% at 100% brightness settings, respectively (all p < 0.01). Highest drop was for the P7 and the Pusen 9.2F. All scopes had illuminance skew, except the V3. All scopes had a warm color temperature.

conclusionIllumination properties vary between ureteroscopes in an enclosed cavity in saline, and differs at center vs 45° and 90° positions within scopes. Peripheral illuminance drop can be as high as - 92%, which is undesirable. This may affect the choice of ureteroscope and light brightness settings used in surgery by urologists.

Indexed as

Equipment DesignKidneyLightingUreteroscopesHumansModels, AnatomicEnclosed cavityFlexible ureteroscopyIlluminanceIllumination propertiesLight distributionSaline

Identifiers

PMID38709327
PMCPMC11074033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.